Cite
MLA Citation
Silvio Danese et al.. “Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.” Lancet gastroenterology and hepatology, vol. 7, 2022, pp. 118–127. http://access.bl.uk/ark:/81055/vdc_100148630927.0x000001